CSL shares have been under pressure, trading near $180, due to softer profits, rising costs, and slow plasma business recovery. Despite recent challenges, CSL's plasma collections, vaccine business, ...

The College Swimming League (CSL), a revolutionary sports enterprise, today unveiled its plans to fundamentally reimagine college swimming. Founded by Robert Kent and Kyle Sockwell, with support from ...

DuPont de Nemours (DD) has quietly drifted lower over the past 3 months even as its one year total return remains solidly positive, which sets up an interesting reset for long term investors. See our ...

A report from the Australian National Audit Office into the ­Seqirus deal – and a separate agreement with US pharmaceutical company Moderna for an mRNA vaccine factory – argues the government strayed ...

CSL shares rose by 4.4% in November, outperforming the ASX 200's 3% loss, amid increasing analyst consensus that the stock is undervalued after a 35% decline over 12 months. Positive momentum was ...

The 1972 BMW 3.0 CSL Werks Development Car (chassis E9/R1) is now available for sale in the U.K. through dealer Dylan Miles This is a unique, factory-used prototype that was instrumental in the ...

Nov 18 (Reuters) - Australian biotech firm CSL (CSL.AX), opens new tab said on Tuesday it would invest $1.5 billion in the U.S. to manufacture plasma-derived therapies, in a move to expand its ...

Amid uncertainty for its vaccine division, CSL is growing the footprint of its bread-and-butter plasma therapies business by pledging a capital investment of about $1.5 billion for U.S.-based ...

CSL Ltd. plunged to the lowest in almost seven years after Australia’s biggest drugmaker postponed plans to spin off its vaccines business, as falling US flu immunizations deepen concern over a ...

As an Amazon Associate, we earn from qualifying purchases. TweakTown may also earn commissions from other affiliate partners at no extra cost to you. For cross-platform compatibility, the Fanatec GT ...

The exit delivers a 3.5x return CSL has grown around 20% annually ECI first invested in CSL in 2020 ECI Partners has exited CSL, a critical IoT connectivity business, into a continuation fund, ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Australian biotechnology ...